|
Recent Newsletters
Private equity investments in cardiology | ICE replacing TEE? | Understanding AI | More from the last week |
Heart Health Highlights: FDA approves new type 2 diabetes drug | An updated look at the DASH diet |
ACC recommends intravascular imaging during PCI | AHA President Michelle Albert | Vericiguat for HF |
TAVR Highlights: New self-expanding valve shows promise | 4,000 TAVRs | How CAD & PCI affect outcomes |
Q&A: Exploring the rise of private equity investments in cardiology | Why imagers need to understand AI |
Vascular & Endovascular Highlights: ISC 2023 in review | TAVR patients with PAD face additional risks |
COVID-19 linked to higher diabetes risk | Practice pays $2M to settle fraud allegations | CAD, PCI & TAVR |